Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Comparative Study of Hepatic and Renal Markers in Treatment of Kala-azar with I.V. Amphotericin B and Oral Miltefosine


Affiliations
1 Department of Pharmacology, Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna, Bihar, India
2 Department of Pharmacology, Patna Medical College, Patna, Bihar, India
3 Department of Biochemistry, Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna, Bihar, India
     

   Subscribe/Renew Journal


This study was designed to compare the hepatic and renal markers in treatment with two most commonly used drugs I.V. Amphotericin B and oral Miltefosine in diagnosed cases of KALA-AZAR. This was an 'OBSERVATIONAL' and 'CROSS-SECTIONAL' study. This study was conducted on two groups each had fifty patients. I.V. Amphotericin B and oral Miltefosine were given to group A and B respectively. Rise of serum bilirubin was not significant (p>0.05) in either group. Mean SGPT and SGOT level were more in group B than that of group A. But the rise in mean SGPT and SGOT level was not statistically significant (p>0.05). Rise in BUN was significant (p<0.01) by the 15th day in Group A patients but it did not cross the normal limit. There was not significant (p 0.05) rise in the mean serum creatinine level during treatment in patients of both groups.

Fall in serum Potassium level was significant (p<0.05) at 22nd and 30th day of treatment in group A patients while the fall was not significant (p>0.05) in group B patients. These results suggest that during treatment hepatic and renal markers were not altered significantly which warrant the withdrawal of the drug in both groups. It is highly recommended that serial monitoring of hepatic and renal markers are useful parameters in anti kala-azar therapy.


Keywords

I.V. Amphotericin B, Oral Miltefosine, Serum bilirubin, SGPT, SGOT, BUN, Serum creatinine, serum Potassium
Subscription Login to verify subscription
User
Notifications
Font Size


Abstract Views: 755

PDF Views: 0




  • Comparative Study of Hepatic and Renal Markers in Treatment of Kala-azar with I.V. Amphotericin B and Oral Miltefosine

Abstract Views: 755  |  PDF Views: 0

Authors

Kumar Manish
Department of Pharmacology, Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna, Bihar, India
Ranjana
Department of Pharmacology, Patna Medical College, Patna, Bihar, India
J. R. Keshari
Department of Biochemistry, Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna, Bihar, India
Sinha Kumari Indu
Department of Pharmacology, Patna Medical College, Patna, Bihar, India

Abstract


This study was designed to compare the hepatic and renal markers in treatment with two most commonly used drugs I.V. Amphotericin B and oral Miltefosine in diagnosed cases of KALA-AZAR. This was an 'OBSERVATIONAL' and 'CROSS-SECTIONAL' study. This study was conducted on two groups each had fifty patients. I.V. Amphotericin B and oral Miltefosine were given to group A and B respectively. Rise of serum bilirubin was not significant (p>0.05) in either group. Mean SGPT and SGOT level were more in group B than that of group A. But the rise in mean SGPT and SGOT level was not statistically significant (p>0.05). Rise in BUN was significant (p<0.01) by the 15th day in Group A patients but it did not cross the normal limit. There was not significant (p 0.05) rise in the mean serum creatinine level during treatment in patients of both groups.

Fall in serum Potassium level was significant (p<0.05) at 22nd and 30th day of treatment in group A patients while the fall was not significant (p>0.05) in group B patients. These results suggest that during treatment hepatic and renal markers were not altered significantly which warrant the withdrawal of the drug in both groups. It is highly recommended that serial monitoring of hepatic and renal markers are useful parameters in anti kala-azar therapy.


Keywords


I.V. Amphotericin B, Oral Miltefosine, Serum bilirubin, SGPT, SGOT, BUN, Serum creatinine, serum Potassium